CM
BHVN

Caption Management’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Caption Management’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-20,400
Closed -$2.97M – 1988
2022
Q2 		$2.97M Sell
20,400
-210,100
-91% -$26.8M 0.04% 542
2022
Q1 		$27.3M Sell
230,500
-41,800
-15% -$5.21M 0.33% 55
2021
Q4 		$37.5M Buy
272,300
+185,500
+214% +$23.6M 0.42% 30
2021
Q3 		$12.1M Sell
86,800
-3,200
-4% -$400K 0.14% 191
2021
Q2 		$8.74M Buy
+90,000
New +$7.3M 0.11% 232
2021
Q1 		– Sell
-306,300
Closed -$26.3M – 1539
2020
Q4 		$26.3M Buy
306,300
+228,800
+295% +$19.4M 0.6% 26
2020
Q3 		$5.04M Sell
77,500
-42,500
-35% -$2.79M 0.12% 215
2020
Q2 		$8.77M Buy
+120,000
New +$6.39M 0.29% 73
2020
Q1 		– Sell
-119,600
Closed -$6.51M – 1254
2019
Q4 		$6.51M Buy
119,600
+41,600
+53% +$2.06M 0.22% 124
2019
Q3 		$3.25M Sell
78,000
-21,300
-21% -$900K 0.17% 166
2019
Q2 		$4.35M Sell
99,300
-700
-0.7% -$39.5K 0.22% 134
2019
Q1 		$5.15M Buy
+100,000
New +$4.32M 0.28% 107

Other funds holding BHVN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
SFM
Soros Fund Management New York $9.12B AUM 30.69% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Caption Management's BHVN Position: Q2 2022 in Review

Caption Management sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q2 2022, closing a stake of 91,500 shares — an estimated $11.7M sold.

Caption Management first reported a position in BHVN in Q1 2019 and held it in 12 quarters. The position peaked at $21.8M in Q4 2020. 329 funds tracked by Wall St. Rank hold BHVN as of Q2 2022.

  • Caption Management reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q2 2022 after selling out during the quarter.
  • Caption Management sold 91,500 Biohaven Pharmaceutical Holding Company Ltd. shares in Q2 2022, an estimated $11.7M.
  • Caption Management first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q1 2019 and held it in 12 quarters.
  • Caption Management's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $21.8M in Q4 2020.
  • 329 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q2 2022.

Based on Caption Management's 13F filing for Q2 2022, filed 15 Aug 2022.